Pharmacokinetics of benperidol in volunteers after oral administration. 1988

M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
Department of Pharmacology, University of Padua, Italy.

Benperidol in a 4 mg single dose was administered orally to five healthy male volunteers. The drug was rapidly absorbed (tmax = 2.27 +/- 0.57 h) and largely distributed, the volume of distribution being 5.19 +/- 1.99 l.kg-1. Elimination half-life was 7.65 +/- 2.14 h. Urinary excretion represented only a minimal fraction of ingested dose (0.1 +/- 0.007%). Variability of the area under the curve makes a first-pass metabolism a reasonable possibility. Acute dystonias appeared in two subjects.

UI MeSH Term Description Entries
D008297 Male Males
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001544 Benperidol A butyrophenone with general properties similar to those of HALOPERIDOL. It has been used in the treatment of aberrant sexual behavior. (From Martindale, The Extra Pharmacopoeia, 30th ed, p567) Anquil,Benperidol-neuraxpharm,Frenactil,Glianimon,Benperidol neuraxpharm,Benperidolneuraxpharm

Related Publications

M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
January 1992, International journal of clinical pharmacology research,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
January 1985, International journal of clinical pharmacology research,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
January 1988, European journal of clinical pharmacology,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
October 1986, British journal of clinical pharmacology,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
December 1992, Journal of pharmaceutical sciences,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
May 2016, International journal of clinical pharmacology and therapeutics,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
April 1986, European journal of clinical microbiology,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
January 1997, The American journal of tropical medicine and hygiene,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
August 1984, European journal of clinical microbiology,
M Furlanut, and P Benetello, and A Perosa, and G Colombo, and F Gallo, and A Forgione
September 1993, Journal of pharmaceutical sciences,
Copied contents to your clipboard!